KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Liabilities from Discontinued Operations: 2015

Historic Liabilities from Discontinued Operations for Emergent BioSolutions (EBS) over the last 1 years, with Dec 2015 value amounting to $17.3 million.

  • Emergent BioSolutions' Liabilities from Discontinued Operations was N/A to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year change of. This contributed to the annual value of $17.3 million for FY2015, which is N/A change from last year.
  • According to the latest figures from FY2015, Emergent BioSolutions' Liabilities from Discontinued Operations is $17.3 million.
  • Emergent BioSolutions' 5-year Liabilities from Discontinued Operations high stood at $17.3 million for FY2015, and its period low was $17.3 million during FY2015.
  • Over the past 1 years, Emergent BioSolutions' median Liabilities from Discontinued Operations value was $17.3 million (recorded in 2015), while the average stood at $17.3 million.